Literature DB >> 27834139

MicroRNA-130a Regulation of Desmocollin 2 in a Novel Model of Arrhythmogenic Cardiomyopathy.

Stefan R Mazurek1, Tyler Calway1, Cynthia Harmon1, Priyanka Farrell1, Gene H Kim1.   

Abstract

BACKGROUND: MicroRNAs are small noncoding RNA molecules that play a critical role in regulating physiological and disease processes. Recent studies have now recognized microRNAs as an important player in cardiac arrhythmogenesis. Molecular insight into arrhythmogenic cardiomyopathy (AC) has primarily focused on mutations in desmosome proteins. To our knowledge, models of AC due to microRNA dysregulation have not been reported. Previously, we reported on miR-130a mediated down-regulation of Connexin43.
OBJECTIVE: Here, we investigate miR-130a-mediated translational repression of Desmocollin2 (DSC2), as it has a predicted target site for miR-130a. DSC2 is an important protein for cell adhesion, which has been shown to be dysregulated in human AC. METHOD &
RESULTS: After induction of miR-130a, transgenic mice demonstrated right ventricular dilation. Surface ECG revealed spontaneous premature ventricular complexes confirming an arrhythmogenic phenotype in αMHC-miR130a mice. Using total protein from whole ventricular lysate, western blot analysis demonstrated an 80% reduction in DSC2 levels in transgenic myocardium. Furthermore, immunofluorescent staining confirmed downregulation of DSC2 in transgenic compared with littermate control myocardium. In transgenic hearts, histologic findings revealed fibrosis and lipid accumulation within both ventricles. To validate DSC2 as a direct target of miR-130a, we performed in vitro target assays in 3T3 fibroblasts, known to express miR-130a. Using a luciferase reporter fused to the 3UTR of DSC2 compared with a control, we found a 42% reduction in luciferase activity with the DSC2 3UTR. This reduction was reversed upon selective inhibition of miR-130a.
CONCLUSION: Overexpression of miR-130a results in a disease phenotype characteristic of AC and therefore, may serve as potential model for microRNA-induced AC. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Arrhythmia; cardiomyopathy; desmocollin 2; desmosome; intercalated disc; miR-130a

Mesh:

Substances:

Year:  2017        PMID: 27834139      PMCID: PMC5732625          DOI: 10.2174/2211536605666161109111031

Source DB:  PubMed          Journal:  Microrna


  26 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 2.  Sudden death from genetic and acquired cardiomyopathies.

Authors:  Srijita Sen-Chowdhry; William J McKenna
Journal:  Circulation       Date:  2012-03-27       Impact factor: 29.690

Review 3.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature.

Authors:  Brittney Murray
Journal:  J Genet Couns       Date:  2012-03-17       Impact factor: 2.537

Review 4.  MicroRNA regulation of cardiac conduction and arrhythmias.

Authors:  Gene H Kim
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

5.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

6.  Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.

Authors:  Torsten B Rasmussen; Peter H Nissen; Johan Palmfeldt; Katja Gehmlich; Søren Dalager; Uffe B Jensen; Won Y Kim; Lene Heickendorff; Henning Mølgaard; Henrik K Jensen; Ulrik T Baandrup; Peter Bross; Jens Mogensen
Journal:  Circ Cardiovasc Genet       Date:  2014-04-04

Review 7.  Pathophysiology of arrhythmogenic cardiomyopathy.

Authors:  Cristina Basso; Barbara Bauce; Domenico Corrado; Gaetano Thiene
Journal:  Nat Rev Cardiol       Date:  2011-11-29       Impact factor: 32.419

8.  A novel desmocollin-2 mutation reveals insights into the molecular link between desmosomes and gap junctions.

Authors:  Katja Gehmlich; Pier D Lambiase; Angeliki Asimaki; Edward J Ciaccio; Elisabeth Ehler; Petros Syrris; Jeffrey E Saffitz; William J McKenna
Journal:  Heart Rhythm       Date:  2011-01-07       Impact factor: 6.343

9.  Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a.

Authors:  Gene H Kim; Sadhana A Samant; Judy U Earley; Eric C Svensson
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

10.  Desmosomal cadherins are decreased in explanted arrhythmogenic right ventricular dysplasia/cardiomyopathy patient hearts.

Authors:  Alexia Vite; Estelle Gandjbakhch; Catherine Prost; Veronique Fressart; Pierre Fouret; Nathalie Neyroud; Françoise Gary; Erwan Donal; Shaida Varnous; Guy Fontaine; Paul Fornes; Françoise Hidden-Lucet; Michel Komajda; Philippe Charron; Eric Villard
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more
  2 in total

Review 1.  Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy.

Authors:  Stefan Mazurek; Gene H Kim
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-04-25       Impact factor: 5.187

Review 2.  MicroRNAs in Cardiac Diseases.

Authors:  Robin M W Colpaert; Martina Calore
Journal:  Cells       Date:  2019-07-18       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.